2017
Treatment Impact on Survival of Early Stage NSCLC: Phramongkutklao Hospital Experience
31.61.018 [Abstract] | [PDF]
Clinical Characteristics and Outcomes of Extremity Soft Tissue Sarcoma in Siriraj Hospital
31.60.016 [Abstract] | [PDF]
Tolerability and Efficacy of Concurrent Chemoradiotherapy Comparing Carboplatin/Paclitaxel vs Platinum/5-FU Regimen for Locally Advanced Esophageal and Esophagogastric Junction Cancers
31.60.015 [Abstract] | [PDF]
Prognostic factors of Survival Outcomes in Thai Colorectal Cancer Patients with Liver Metastasis
31.60.014 [Abstract] | [PDF]
Isocitrate Dehydrogenase1 and 2 Mutations in Thai Patients with Cholangiocarcinoma
31.60.013 [Abstract] | [PDF]
Role of Metformin, Aspirin and Statin in Cancer Prevention: A Population- Based Study
31.60.012 [Abstract] | [PDF]
Predisposing factors associated with chemotherapy toxicity in elderly cancer patients: A prospective study
31.60.011 [Abstract] | [PDF]
Early Palliative Care Reduced the Aggressiveness of Cancer Care near End of Life in Metastatic Non Small Cell Lung Cancer Patients
31.60.010 [Abstract] | [PDF]
Expected Years of Life Loss and Survival Outcome in Non-small Cell Lung Cancer Patients in Rajavithi Hospital
31.60.009 [Abstract] | [PDF]
Nutritional and systemic inflammatory response parameter and survival outcomes in the inoperable non-small cell lung cancer patients treated with palliative chemotherapy in Rajavithi hospital
31.60.008 [Abstract] | [PDF]
Outcome of treatment with 2nd or 3rd line TKI in Recurrent/Advance NSCLC Patients In Maharaj Nakhon Chiangmai Hospital
31.60.007 [Abstract] | [PDF]
The efficacy of Bevacizumab adding in standard first line chemotherapy and maintenance treatment in advanced stage NSCLC: a systematic review and network meta-analysis
31.60.006 [Abstract] | [PDF]
Obesity and outcome of operable breast cancer in Thai patient: A single center study
31.60.005 [Abstract] | [PDF]
Correlation between of serum 25-hydroxyvitamin D (25(OH)D) level and bone mineral density (BMD) change in postmenopausal women with early breast cancer receiving aromatase inhibitors
31.60.004 [Abstract] | [PDF]
A double-blind, placebo-controlled randomized phase II study: evaluating the effect of curcumin for treatment of cancer anorexia–cachexia syndrome in solid cancer patients.
31.60.003 [Abstract] | [PDF]
A Clinicopathological Prediction Model for Recurrence in Patients with Early-staged Hormonal Receptor Positive, Her-2 Negative Breast Cancer at King Chulalongkorn Memorial Hospital
31.60.002 [Abstract] | [PDF]
Change of Programmed Cell Death 1 Ligand Expression in Non Small Cell Lung Carcinoma Harboring Somatic Epidermal Growth Factor Receptor (EGFR) Mutations Correlated with EGFR Tyrosine Kinase Inhibitors Exposure
31.60.001 [Abstract] | [PDF]